EU opens in-depth probe into J&J's $400M purchase of Takeda's surgical patch

The European Commission opened an in-depth investigation into Johnson & Johnson's planned $400 million acquisition of a surgical patch from Takeda Pharmaceuticals, citing competition concerns.

“Europe's competition enforcer opened an in-depth investigation on Wednesday into Johnson & Johnson's planned $400 million purchase of a surgical patch from Takeda Pharmaceuticals”law360.com

• 1 source
• law360.comEU Probing J&J's $400M Deal For Takeda's Surgical Patch - Law360Matthew PerlmanMar 25, 2020

Summarized from public sources; check the original articles before acting on it.